Skip to main content

Table 1 Baseline characteristics, mean (SD) and percentage.

From: Prevalence of lipid abnormalities before and after introduction of lipid modifying therapy among Swedish patients with dyslipidemia (PRIMULA)

 

Male (n = 2509)

Female (n = 2915)

Total (n = 5424)

Age (years)

68.1 (10.8)

70.5 (10.3)

69.4 (10.6)

Cardiovascular (CV) risk factors

   

Current smoker

29%

31%

30%

Hypertension > 140/90 mmHg or medication

87%

89%

88%

Hypertension medication use at baseline

60%

62%

61%

Baseline systolic blood pressure (mmHg)

147.1 (17.4)

150.6 (18.6)

148.9 (18.1)

Baseline diastolic blood pressure (mmHg)

85.1 (9.0)

83.9 (8.6)

84.4 (8.8)

TC (mmol/l)

6.6 (1.3)

7.1 (1.2)

6.9 (1.3)

LDL-C (mmol/l)

4.3 (1.2)

4.7 (1.2)

4.5 (1.2)

TG (mmol/l)

2.5 (2.0)

2.2 (1.5)

2.4 (1.8)

HDL-C (mmol/l)

1.2 (0.3)

1.5 (0.5)

1.4 (0.4)

HbA1c (%-units)

6.2 (1.4)

6.0 (1.4)

6.1 (1.4)

Type 2 diabetes mellitus

28%

22%

25%

Age at diabetes onset (years)

59.7 (10.1)

61.3 (10.1)

60.5 (10.1)

Diabetes duration (years)

8.9 (3.5)

9.5 (3.5)

9.2 (3.5)

Obesity (BMI ≥ 30)

38%

42%

40%

CHD (1)

11%

8%

10%

Diabetes without CHD (2)

25%

21%

23%

Framingham Risk Score >20% without CHD or diabetes (3)

12%

2%

7%

Any of the criteria (1) - (3)

46%

30%

38%

  1. To convert the values for cholesterol to mg/dL, multiply by 1/0.02586. To convert the values for triglycerides to mg/dL, multiply by 1/0.01129.
  2. TC = total cholesterol, LDL-C = low-density lipoprotein, TG = triglycerides, HDL-C = high-density lipoprotein.